Comparing Blood Loss, RBC Transfusions and Inflammatory Marker Changes Among Methods of CPB
Completed
- Conditions
- First Posted Date
- 2010-03-10
- Last Posted Date
- 2013-08-23
- Lead Sponsor
- Baylor Research Institute
- Target Recruit Count
- 102
- Registration Number
- NCT01083914
- Locations
- 🇺🇸
The Heart Hospital at Baylor Plano, Plano, Texas, United States
The Natural History of Mucolipidosis Type IV
- Conditions
- First Posted Date
- 2010-02-12
- Last Posted Date
- 2018-07-18
- Lead Sponsor
- Baylor Research Institute
- Target Recruit Count
- 35
- Registration Number
- NCT01067742
- Locations
- 🇺🇸
Baylor Institute of Metabolic Disease, Dallas, Texas, United States
Fabry Screening Study
Completed
- Conditions
- First Posted Date
- 2009-11-25
- Last Posted Date
- 2018-02-13
- Lead Sponsor
- Baylor Research Institute
- Target Recruit Count
- 2724
- Registration Number
- NCT01019629
- Locations
- 🇺🇸
Baylor Institute of Metabolic Disease, Dallas, Texas, United States
The Effectiveness of Silver Alginate (Algidex) Patch in the Prevention of Central Line Infections in Very Low Birth Weight Infants
- First Posted Date
- 2009-08-24
- Last Posted Date
- 2015-03-17
- Lead Sponsor
- Baylor Research Institute
- Target Recruit Count
- 300
- Registration Number
- NCT00964093
- Locations
- 🇺🇸
Baylor University Medical Center - Women and Children's Services, Dallas, Texas, United States
Triheptanoin Treatment Trial for Patients With Adult Polyglucosan Body Disease
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-07-28
- Last Posted Date
- 2018-03-05
- Lead Sponsor
- Baylor Research Institute
- Target Recruit Count
- 23
- Registration Number
- NCT00947960
- Locations
- 🇫🇷
Department of Genetics, Groupe Hospitalier Pitié-Salpêtrière, Paris, France
Study of Stem Cell Transplant for Leukemia and Myelodysplastic Syndromes Using Clofarabine and Busulfan Regimen
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-02-26
- Last Posted Date
- 2013-04-04
- Lead Sponsor
- Baylor Research Institute
- Target Recruit Count
- 20
- Registration Number
- NCT00852163
- Locations
- 🇺🇸
Baylor University Medical Center, Dallas, Texas, United States
Vaccination of HIV-1 Infected Patients With Dendritic Cells in Addition to Antiretroviral Treatment - (DALIA Trial)
- First Posted Date
- 2008-11-24
- Last Posted Date
- 2017-06-12
- Lead Sponsor
- Baylor Research Institute
- Target Recruit Count
- 19
- Registration Number
- NCT00796770
- Locations
- 🇺🇸
Baylor University Medical Center, Dallas, Texas, United States
Comparison Study of Dendritic Cell Vaccine With and Without Cyclophosphamide to Treat Stage IV Melanoma Patients
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2008-07-25
- Last Posted Date
- 2013-07-08
- Lead Sponsor
- Baylor Research Institute
- Target Recruit Count
- 9
- Registration Number
- NCT00722098
- Locations
- 🇺🇸
Baylor University Medical Center, Dallas, Texas, United States
Intratumoral Dendritic Cell Vaccination Combined With Local Radiotherapy in Patients With Recurrent Lymphoma.
Phase 1
Withdrawn
- Conditions
- First Posted Date
- 2008-03-17
- Last Posted Date
- 2017-06-12
- Lead Sponsor
- Baylor Research Institute
- Registration Number
- NCT00637117
A Study to Examine Levels of Sedation During Outpatient Colonoscopies
Completed
- Conditions
- First Posted Date
- 2008-02-13
- Last Posted Date
- 2017-06-12
- Lead Sponsor
- Baylor Research Institute
- Target Recruit Count
- 100
- Registration Number
- NCT00614263
- Locations
- 🇺🇸
Baylor University Medical Center - Department of Anesthesiology, Dallas, Texas, United States
© Copyright 2024. All Rights Reserved by MedPath